Use of personal continuous glucose monitoring device is associated with reduced risk of hypoglycemia in a 16-week clinical trial of people with type 1 diabetes

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftDiabetes Technology & Therapeutics
ISSN1520-9156
StatusAccepteret/In press - 2021
Begivenhed14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2021) - Virtual
Varighed: 2 jun. 20215 jun. 2021
https://attd.kenes.com/

Konference

Konference14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2021)
LokationVirtual
Periode02/06/202105/06/2021
Internetadresse

Citationsformater